BGS 2456
Alternative Names: BGS-2456Latest Information Update: 05 Mar 2024
At a glance
- Originator BridGene Biosciences
- Class Antineoplastics; Small molecules
- Mechanism of Action Fms-like tyrosine kinase 3 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer